Lincoln Pharmaceuticals Ltd Share Price
(LINCOLN)
₹582.65
as on 04:01PM, 29 Apr 2025
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 5.51 % |
3 Month Return | -16.68 % |
1 Year Return | -3.63 % |
Market Stats | |
Previous Close | ₹588.60 |
Open | ₹595.60 |
Volume | 28.94K |
Upper Circuit | ₹706.30 |
Lower Circuit | ₹470.90 |
Market Cap | ₹1,167.03Cr |
P/E Ratio
13.06
PEG Ratio
12.44
Market Cap
₹1,167.03 Cr
P/B Ratio
1.98
EPS
46.58
Dividend Yield
0.31
Sector
Pharmaceuticals
ROE
17.04
Funds | Holdings | Prev. 5M |
---|---|---|
![]() | 0.04% |
Lincoln Pharmaceuticals Surges 7.83% on December 30 - 30 Dec, 2024
Lincoln Pharmaceuticals Hits Upper Circuit with Strong Performance - 03 Dec, 2024
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 7 days, LINCOLN stock has moved up by 1.9%
Retail Holding Up
Retail Investor have increased holdings from 45.06% to 45.22% in Mar 2025 quarter
Promoter Holding Unchanged
Promoters holdings remained unchanged at 49.78% of holdings in Mar 2025 quarter
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 137.0% return, outperforming this stock by 58.3%
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 51.1% return, outperforming this stock by 52.0%
Profit Down
Netprofit is down for the last 2 quarters, 26.33 Cr → 20.77 Cr (in ₹), with an average decrease of 21.1% per quarter
Revenue Fall
Revenue is down for the last 2 quarters, 171.19 Cr → 155.52 Cr (in ₹), with an average decrease of 9.2% per quarter
FII Holding Down
Foreign Institutions have decreased holdings from 5.16% to 5.00% in Mar 2025 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 49.78% | 0.00 | |
Foreign Institutions | 5% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 45.22% | 0.00 | |
Others | 0% | 0.00 |
Lincoln Pharmaceuticals Ltd in the last 5 years
Lowest (3.58x)
March 23, 2020
Today (13.06x)
April 29, 2025
Industry (54.77x)
April 29, 2025
Highest (19.77x)
December 9, 2024
Lincoln Pharmaceuticals Ltd’s net profit fell -25.93% since last year same period to ₹20.77Cr in the Q3 2024-2025. On a quarterly growth basis, Lincoln Pharmaceuticals Ltd has generated -21.12% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, Lincoln Pharmaceuticals Ltd has declared dividend of ₹1.80 - translating a dividend yield of 0.57%.
Read More about DividendsBearish
Neutral
Bullish
Lincoln Pharmaceuticals Ltd is currently in a Bullish trading position according to technical analysis indicators.
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹1,167.03 Cr | 56.06% | 0.50 | ₹93 Cr | ₹580 Cr | |
NA | ₹147.07 Cr | 35.43% | 0.62 | NA | NA | |
NA | ₹5,411.31 Cr | 432.02% | 0.50 | ₹33 Cr | ₹204 Cr | |
NA | ₹1,510.04 Cr | 381.87% | 0.52 | NA | NA | |
NA | ₹3,596.41 Cr | 157.18% | 0.51 | NA | NA |
Organisation | Lincoln Pharmaceuticals Ltd |
Headquarters | Ahmedabad |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Lincoln Pharmaceuticals Ltd share price today stands at ₹582.65, Open: ₹595.6, Previous Close: ₹588.6, High: ₹605.2, Low: ₹576.9, 52 Week High: ₹979.5, 52 Week Low: ₹499.
Today's traded volume of Lincoln Pharmaceuticals Ltd(LINCOLN) is 28.94K.
Today's market capitalisation of Lincoln Pharmaceuticals Ltd(LINCOLN) is ₹1167.03Cr.
Lincoln Pharmaceuticals Ltd (LINCOLN) share price is ₹582.65. It is down -40.52% from its 52 Week High price of ₹979.5
Lincoln Pharmaceuticals Ltd (LINCOLN) share price is ₹582.65. It is up 16.76% from its 52 Week Low price of ₹499